BCL2 and breast carcinoma: Further research is needed to identify the proteins involved in the molecular mechanisms underlying compound (1) through the expression of p53 protein, mutant p53, Bcl-2, and NF-Kß as well as through other signal transduction both in vitro and in vivo on cells breast cancer.